The Effectiveness of Virtual Training on the MiniMed™ 670G System in People with Type 1 Diabetes During the COVID-19 Pandemic.

The Effectiveness of Virtual Training on the MiniMed™ 670G System in People with Type 1 Diabetes During the COVID-19 Pandemic.
复制标题

DOI:
10.1089/dia.2020.0234
复制
发表时间:
2021-03
影响因子:
5.4
通讯作者:
Cordero TL
Cordero TL
中科院分区:
医学3区
文献类型:
--
作者:
Vigersky RA;Velado K;Zhong A;Agrawal P;Cordero TL

文献摘要

参考文献

被引文献

相似文献

背景:冠状病毒病2019年(新冠肺炎)大流行挑战了就先进糖尿病管理技术进行面对面培训的能力。在美国,美敦力糖尿病公司于2020年3月中旬从偶尔对所有糖尿病设备进行虚拟培训转变为100%虚拟培训。我们研究了在MINMED™670G混合闭环系统上对1型糖尿病患者进行虚拟训练的结果。方法:从2020年3月20日至2020年4月22日(新冠肺炎内部),使用Zoom完成对MiniMed 670G系统的虚拟培训,并通过在线培训后调查获取满意度。培训效率的衡量标准是产品发货之日与第一次和最后一次培训之日之间的天数。患者对MiniMed 670G培训的满意度由Net Promotor Score®(NPS®)确定。记录了来自CareLink™Personal和CareLink专业人员的上传,以及致电美敦力24小时技术支持团队,请求教育/软件援助和/或医疗保健提供者远程医疗访问的帮助。连续血糖监测(CGM)结果使用CareLink个人数据库进行测量。除Zoom满意度调查外,所有结果都与2020年1月20日至2020年2月22日(新冠肺炎之前)的数据进行了比较,当时培训是面对面进行的。结果:新冠肺炎培训前和培训中的CGM指标是相似的。Zoom视频会议应用程序的满意度为98%。NPS从78上升到84。从泵到第一次和最后一次(自动)培训的时间分别从14 ± 7天减少到11 ± 5天(P < 0.001)和从19 ± 7天减少到15 ± 15天(P < 0.01)。要求向技术支助小组提供教育援助的请求有所减少,但要求提供登录和软件安装支持的请求有所增加。结论:在MiniMed 670G系统上对糖尿病患者进行虚拟培训可获得与面对面培训相当的高满意度和短期的血糖控制效果。
Background: The coronavirus disease 2019 (COVID-19) pandemic has challenged the ability to do face-to-face training on advanced diabetes management technologies. In the United States, Medtronic Diabetes shifted from occasional to 100% virtual training on all diabetes devices in mid-March 2020. We studied the outcomes of virtual training on the MiniMed™ 670 G hybrid closed-loop system in type 1 diabetes. Methods: From March 20, 2020, to April 22, 2020 (intra-COVID-19), virtual training on the MiniMed 670 G system was completed using Zoom with satisfaction captured through online post-training surveys. Training efficiency was measuring by the days between the date of product shipment and the date of the first and final trainings. Patient satisfaction with training on the MiniMed 670 G was determined by Net Promotor Score® (NPS®). Uploads from CareLink™ Personal and CareLink Professional and calls to the Medtronic 24-h technical support team requesting educational/software assistance and/or help with health care provider telehealth visits were recorded. Continuous glucose monitoring (CGM) results were measured using the CareLink Personal database. All results except for the Zoom satisfaction survey were compared with data from January 20, 2020, to February 22, 2020, (Pre-COVID-19) when training was performed in-person. Results: The CGM metrics were comparable between pre- and intra-COVID-19 training. The Zoom video conferencing application had 98% satisfaction. The NPS rose from 78 to 84. The time between the pump shipment and the first and last (automode) training was significantly reduced from 14 ± 7 days to 11 ± 5 days (P < 0.001) and from 19 ± 7 days to 15 ± 15 days (P < 0.01), respectively. There was a decrease in the calls for educational assistance to the technical support team but an increase in requests for login and software installation support. Conclusions: Virtual training of individuals with diabetes on the MiniMed 670 G system resulted in high satisfaction and short-term glycemic results comparable with in-person training.
DOI: 10.1089/dia.2018.0202
发表时间: 2018-10-01
影响因子: 5.4
作者:
Stone, Michael P.;Agrawal, Pratik;Kaufman, Francine R.
通讯作者: Kaufman, Francine R.